MARKET

PAHC

PAHC

Phibro Animl
NASDAQ

Real-time Quotes | Nasdaq Last Sale

23.10
+0.46
+2.01%
Opening 11:22 03/31 EDT
OPEN
22.60
PREV CLOSE
22.64
HIGH
23.37
LOW
21.72
VOLUME
52.01K
TURNOVER
--
52 WEEK HIGH
36.98
52 WEEK LOW
16.87
MARKET CAP
934.28M
P/E (TTM)
24.73
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of PAHC and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 6 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average PAHC stock price target is 22.75 with a high estimate of 25.00 and a low estimate of 18.00.

EPS

PAHC News

More
  • Zooming in on NASDAQ:PAHC's 2.4% Dividend Yield
  • Simply Wall St. · 3d ago
  • Baxter (BAX) Looks Good: Stock Adds 5.1% in Session
  • Zacks · 03/19 15:35
  • Why Is Phibro (PAHC) Down 7.9% Since Last Earnings Report?
  • Zacks · 03/04 16:30
  • Why It Might Not Make Sense To Buy Phibro Animal Health Corporation (NASDAQ:PAHC) For Its Upcoming Dividend
  • Simply Wall St. · 02/27 14:54

Industry

Pharmaceuticals
-0.06%
Pharmaceuticals & Medical Research
-0.13%

Hot Stocks

Symbol
Price
%Change

About PAHC

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products. The Company also manufactures and markets specific ingredients for use in the personal care, automotive, industrial chemical and chemical catalyst industries. The Company's Medicated Feed Additives (MFAs) and other business consist of concentrated medicated products, which are administered through animal feeds. The Company's MFAs and other business consists of the production and sale of antibacterials, including Stafac, Terramycin, Neo-Terramycin and Mecadox and anticoccidials, including Nicarb, Aviax, Aviax Plus, Coxistac and amprolium.
More

Webull offers kinds of Phibro Animal Health Corp stock information, including NASDAQ:PAHC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PAHC stock news, and many more online research tools to help you make informed decisions.